Clinical Trial Update: Ceftriaxone for Post-Treatment Lyme Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating ceftriaxone for Post-Treatment Lyme Disease Syndrome is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-treatment Lyme Disease Syndrome

Drugs mentioned

• ceftriaxone (ceftriaxone sodium)

Snippet

Sponsor: Hackensack Meridian Health | Conditions: Post-Treatment Lyme Disease Syndrome | Phase 1, Phase 2 | Status: RECRUITING